Cuéllar-Rodríguez J

Idioma: Español
Referencias bibliográficas: 17
Paginas: 44-52
Archivo PDF: 269.52 Kb.

FRAGMENTO

El propósito de esta evaluación es determinar el riesgo de complicaciones infecciosas posteriores al trasplante renal y establecer medidas de prevención.

El escrutinio general puede ser llevado a cabo por el equipo médico de trasplante, sin embargo, todos aquellos pacientes que son considerados de alto riesgo para desarrollar un evento infeccioso o aquéllos con una infección activa durante la valoración previa al trasplante renal deberán ser evaluados por el Servicio de Infectología.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Malinis M, Boucher HW, AST Infectious Diseases Community of Practice. Screening of donor and candidate prior to solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33 (9): e13548. doi: 10.1111/ctr.13548.

2. Kasiske BL, Cangro CB, Hariharan S, Hricik DE, Kerman RH, Roth D et al. The evaluation of renal transplantation candidates: clinical practice guidelines. Am J Transplant. 2001; 1 (Suppl 2): 3-95.

3. Avery RK. Recipient screening prior to solid-organ transplantation. Clin Infect Dis. 2002; 35 (12): 1513-1519.

4. Fischer SA, Avery RK; AST Infectious Disease Community of Practice. Screening of donor and recipient prior to solid organ transplantation. Am J Transplant. 2009; 9 Suppl 4: S7-18.

5. Delmonico FL. Cadaver donor screening for infectious agents in solid organ transplantation. Clin Infect Dis. 2000; 31 (3): 781-786.

6. Subramanian AK, Theodoropoulos NM; Infectious Diseases Community of Practice of the American Society of Transplantation. Mycobacterium tuberculosis infections in solid organ transplantation: Guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transplant. 2019; 33 (9): e13513. doi: 10.1111/ctr.13513.

7. Jung JY, Joo DJ, Lee CH, Park MS, Kim YS, Kim MS et al. Pre-transplant risk factors for tuberculosis after kidney transplant in an intermediate burden area. Int J Tuberc Lung Dis. 2012; 16 (2): 248-254.

8. Torre-Cisneros J, Doblas A, Aguado JM, San Juan R, Blanes M, Montejo M et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis. 2009; 48 (12): 1657-1665.

9. Morris MI, Daly JS, Blumberg E, Kumar D, Sester M, Schluger N et al. Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report. Am J Transplant. 2012; 12 (9): 2288-2300.

10. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33 (9): e13512. doi: 10.1111/ctr.13512.

11. Humar A, Mazzulli T, Moussa G, Razonable RR, Paya CV, Pescovitz MD et al. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant. 2005; 5 (5): 1065-1070.

12. Humar A, Lebranchu Y, Vincenti F, Blumberg EA, Punch JD, Limaye AP et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant. 2010; 10 (5): 1228-1237.

13. Razonable RR, Hayden RT. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin Microbiol Rev. 2013; 26 (4): 703-727.

14. Danziger-Isakov L, Kumar D, AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant. 2019; 33 (9): e13563. doi: 10.1111/ctr.13563.

15. Pergam SA, Limaye AP, AST Infectious Diseases Community of Practice. Varicella zoster virus in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019; 33 (9): e13622. doi: 10.1111/ctr.13622.

16. Blanchard-Rohner G, Enriquez N, Lemaître B, Cadau G, Combescure C, Giostra E et al. Usefulness of a systematic approach at listing for vaccine prevention in solid organ transplant candidates. Am J Transplant. 2019; 19 (2): 512-521. doi: 10.1111/ajt.15097.

17. Chong PP, Avery RK. A Comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients. Clin Ther. 2017; 39 (8): 1581-1598. doi: 10.1016/j.clinthera.2017.07.005.